14.41
price up icon0.84%   0.12
pre-market  시장 영업 전:  14.46   0.05   +0.35%
loading

Novocure Ltd 주식(NVCR)의 최신 뉴스

pulisher
Jan 06, 2026

Voya Investment Management LLC Sells 64,539,786 Shares of NovoCure Limited $NVCR - MarketBeat

Jan 06, 2026
pulisher
Dec 31, 2025

NovoCure Ltd (NVCR) Product Pipeline Analysis Report 2025ResearchAndMarkets.com - Bluefield Daily Telegraph

Dec 31, 2025
pulisher
Dec 29, 2025

Why NovoCure Limited stock could be next big winnerChart Pattern Recognition & View Live Stock Forecasts Instantly - bollywoodhelpline.com

Dec 29, 2025
pulisher
Dec 25, 2025

NovoCure (NVCR): Assessing Valuation After a Recent Rebound From Multi‑Month Lows - Yahoo Finance UK

Dec 25, 2025
pulisher
Dec 25, 2025

NovoCure (NVCR): Exploring Valuation After a Recent Share Price Rebound - simplywall.st

Dec 25, 2025
pulisher
Dec 24, 2025

Has NovoCure’s Tumor Treating Fields Progress Created a Value Opportunity After the 2025 Share Slump? - Yahoo Finance

Dec 24, 2025
pulisher
Dec 23, 2025

Novocure (NVCR) Q2 2025 Earnings Call Transcript - AOL.com

Dec 23, 2025
pulisher
Dec 23, 2025

NovoCure (NVCR) Q3 2024 Earnings Call Transcript - The Globe and Mail

Dec 23, 2025
pulisher
Dec 22, 2025

First Week of February 2026 Options Trading For NovoCure (NVCR) - Nasdaq

Dec 22, 2025
pulisher
Dec 22, 2025

How to hear Novocure’s CEO speak at the J.P. Morgan healthcare event - Stock Titan

Dec 22, 2025
pulisher
Dec 21, 2025

NovoCure Limited (NASDAQ:NVCR) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat

Dec 21, 2025
pulisher
Dec 19, 2025

MACD Signal: How analysts rate NovoCure Limited stock todayTrend Reversal & Capital Efficient Trade Techniques - Улправда

Dec 19, 2025
pulisher
Dec 18, 2025

How analysts rate NovoCure Limited stock todayCEO Change & Smart Money Movement Tracker - Улправда

Dec 18, 2025
pulisher
Dec 17, 2025

CapEx per share of NovoCure Ltd. – MUN:038 - TradingView — Track All Markets

Dec 17, 2025
pulisher
Dec 13, 2025

Wells Fargo Keeps Their Hold Rating on NovoCure (NVCR) - The Globe and Mail

Dec 13, 2025
pulisher
Dec 12, 2025

NovoCure (NVCR): Assessing Valuation After the CEO Transition From Ashley Cordova to Frank Leonard - simplywall.st

Dec 12, 2025
pulisher
Dec 12, 2025

NovoCure’s LUNAR-2 Study: A New Horizon in Lung Cancer Treatment - MSN

Dec 12, 2025
pulisher
Dec 09, 2025

Does NovoCure’s (NVCR) Internal CEO Transition Reinforce or Recast Its Tumor Treating Fields Strategy? - simplywall.st

Dec 09, 2025
pulisher
Dec 09, 2025

Marshall Wace LLP Sells 392,992 Shares of NovoCure Limited $NVCR - MarketBeat

Dec 09, 2025
pulisher
Dec 05, 2025

NovoCure (NVCR): Assessing Valuation After a Steep Drawdown and Recent Share Price Uptick - simplywall.st

Dec 05, 2025
pulisher
Dec 04, 2025

Does NovoCure's (NVCR) Insider CEO Transition Strengthen Its Long-Term Oncology Strategy Or Limit Change? - Yahoo Finance

Dec 04, 2025
pulisher
Dec 04, 2025

NovoCure (NASDAQ:NVCR) Stock Price Up 7%Time to Buy? - MarketBeat

Dec 04, 2025
pulisher
Dec 04, 2025

What is the fair value estimate for NovoCure Limited (038) stock in 2025Weekly Trade Report & Verified Stock Trade Ideas - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Edgestream Partners L.P. Increases Holdings in NovoCure Limited $NVCR - Defense World

Dec 04, 2025
pulisher
Dec 04, 2025

Is NovoCure’s 93% Five Year Share Price Slide Now Creating an Opportunity in 2025? - Yahoo Finance

Dec 04, 2025
pulisher
Dec 03, 2025

NovoCure Limited $NVCR Shares Purchased by American Century Companies Inc. - MarketBeat

Dec 03, 2025
pulisher
Dec 02, 2025

NovoCure stock rating reiterated at Buy by H.C. Wainwright amid CEO change - Investing.com Nigeria

Dec 02, 2025
pulisher
Dec 02, 2025

NovoCure (NASDAQ:NVCR) Shares Gap DownShould You Sell? - MarketBeat

Dec 02, 2025
pulisher
Dec 02, 2025

Can NovoCure's Tumor Treating Fields Redefine Cancer Care By 2026? - RTTNews

Dec 02, 2025
pulisher
Dec 01, 2025

Novocure names Frank Leonard as new CEO, replacing Ashley Cordova By Investing.com - Investing.com Australia

Dec 01, 2025
pulisher
Dec 01, 2025

How Investors Are Reacting To NovoCure (NVCR) CEO Transition as Frank Leonard Takes the Helm - simplywall.st

Dec 01, 2025
pulisher
Dec 01, 2025

Novocure CEO Ashley Cordova resigns, Frank Leonard succeeds - TipRanks

Dec 01, 2025
pulisher
Dec 01, 2025

Novocure (NVCR) Appoints New CEO Amid Leadership Change - GuruFocus

Dec 01, 2025
pulisher
Dec 01, 2025

Novocure names Frank Leonard as new CEO, replacing Ashley Cordova - Investing.com India

Dec 01, 2025
pulisher
Dec 01, 2025

Novocure Ltd Announces CEO Transition - TradingView

Dec 01, 2025
pulisher
Dec 01, 2025

Novocure (NASDAQ: NVCR) elevates President Frank Leonard to CEO as Ashley Cordova resigns - Stock Titan

Dec 01, 2025
pulisher
Dec 01, 2025

Novocure Appoints Company President Frank Leonard as Chief Executive Officer - Yahoo Finance

Dec 01, 2025
pulisher
Nov 27, 2025

NovoCure (NASDAQ:NVCR) Stock Crosses Below 50-Day Moving AverageTime to Sell? - MarketBeat

Nov 27, 2025
pulisher
Nov 26, 2025

Novocure (NASDAQ: NVCR) to Present at 37th Piper Sandler Healthcare Conference on Dec. 2 - Stock Titan

Nov 26, 2025
pulisher
Nov 21, 2025

NovoCure Limited (NVCR) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 21, 2025
pulisher
Nov 19, 2025

Will NovoCure Limited stock attract more institutional investorsInsider Buying & Breakout Confirmation Trade Signals - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Novocure at Jefferies London: Expanding Horizons in Cancer Treatment By Investing.com - Investing.com South Africa

Nov 19, 2025
pulisher
Nov 19, 2025

Tangible book value per share of NovoCure Ltd. – DUS:038 - TradingView

Nov 19, 2025
pulisher
Nov 19, 2025

Published on: 2025-11-19 05:31:32 - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will NovoCure Limited stock benefit from green energy trendsPrice Action & AI Forecasted Entry/Exit Points - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Novocure at Jefferies London: Expanding Horizons in Cancer Treatment - Investing.com India

Nov 19, 2025
$299.17
price up icon 1.64%
medical_devices STE
$259.20
price down icon 0.32%
$70.10
price up icon 0.30%
medical_devices PHG
$29.12
price up icon 1.46%
$85.76
price down icon 1.12%
medical_devices EW
$84.83
price down icon 1.19%
자본화:     |  볼륨(24시간):